CRIDCam
CRID is a Cameroonian not-for-profit research institution founded in 2017 that conducts internationally recognized research on vector-borne infectious diseases (malaria, sleeping sickness, Zika, dengue), serving national malaria control programs, African ministries of health, academic researchers, and global health funders.
- Company typePrivate
- Founded2017
- HeadquartersYaoundé, Cameroon
- Headcount11–50
- GTM typeB2B
- OfferingServices
What CRIDCam does
CRID (Centre for Research in Infectious Diseases) is a not-for-profit research institution founded in 2017 and headquartered in Yaoundé, Cameroon. It conducts high-quality, internationally recognized research on major vector-borne infectious diseases in Africa, including malaria, sleeping sickness, yellow fever, and emerging threats such as Zika and dengue. The centre is led by Executive Director Professor Charles Wondji and serves national malaria control programmes, African ministries of health, academic and research institutions, and international health organizations including WHO, PMI, and the Bill and Melinda Gates Foundation.
The organization operates an integrated technical platform comprising three core facilities: a Molecular Biology Laboratory for genetic and genomic studies of vectors and pathogens (gene amplification, cloning, Sanger sequencing, genotyping); a Biosafety Level 2 Insectary for rearing mosquitoes and conducting insecticide testing; and an Experimental Field Station in Mibellon, Adamawa Region, for small-scale field trials on insecticide resistance and bed nets. It also offers Sanger sequencing services to external researchers and operates the African Centre for Vector Genomics (AVecGen), a Gates Foundation-funded training programme delivering specialized courses in bioinformatics, R programming, molecular entomology, and population genomics to African scientists.
CRID's revenue is generated almost exclusively through research grants and donor funding from international bodies including the Bill and Melinda Gates Foundation (notably a $3.7M grant in October 2020), Wellcome Trust, UKRI/Global Challenges Research Fund, the EU's IMPACTING programme, PMI via Abt Associates under the Vectorlink project, Unitaid, the Science for Africa Foundation, and the Medical Research Foundation (UK). Go-to-market is event- and partnership-driven, relying on scientific conference participation, training-program recruitment, publications, and direct collaborations with national malaria control programmes and international research consortia. CRID has 12 employees and serves as the designated analytical laboratory for all PMI/Vectorlink entomological samples collected in Cameroon, giving it an unusually concentrated role in national vector surveillance.
CRIDCam firmographics
Firmographics- Name
- CRIDCam
- Legal name
- Centre for Research in Infectious Diseases
- Website
- https://crid-cam.com
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CRID is a Cameroonian not-for-profit research institution founded in 2017 that conducts internationally recognized research on vector-borne infectious diseases (malaria, sleeping sickness, Zika, dengue), serving national malaria control programs, African ministries of health, academic researchers, and global health funders.
- Ownership category
- akta.pro rank
CRIDCam industry classification
Industry- Product category
- Infectious Disease Research Services
- NAICS
- Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Patient Recruitment, Site Feasibility & Trial Enablement CROs (HLAGAAAI)
- akta.pro secondary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
Keywords
Where CRIDCam is headquartered
LocationHeadquarters
- HQ city
- Yaoundé
- HQ country
- Cameroon
- HQ region
- Africa
Offices2 records
Markets served
CRIDCam business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure
Revenue model
- Research Grants and Donor Funding: CRID operates as a not-for-profit research institution funded primarily through international research grants and donor funding from organizations such as the Bill and Melinda Gates Foundation, Wellcome Trust, UKRI, EU (IMPACTING programme), and others.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels4 records
CRIDCam product offering
Product offeringCore offering
CRIDCam (Centre for Research in Infectious Diseases) is a not-for-profit research institution based in Yaoundé, Cameroon, that conducts applied research on vector-borne infectious diseases — principally malaria and its Anopheles vectors — and provides specialized laboratory services, training programmes, and core research facilities. Its service portfolio includes Sanger sequencing, molecular vector surveillance, the AVecGen training curriculum (Bioinformatics and Vector Genomics, and Molecular Vector Surveillance), and access to its Molecular Biology Laboratory, Insectary, and Experimental Field Station for partner institutions and public-health agencies.
Product overview
CRID (Centre for Research in Infectious Diseases) is a not-for-profit research institution, not a commercial product company. It provides research services and core laboratory facilities rather than software products. The organization's main offerings include: a Molecular Biology Laboratory for genetic/genomic studies, a Biosafety Level 2 Insectary for mosquito rearing, an Experimental Field Station for field trials, and Sanger Sequencing Services. CRID also runs the African Centre for Vector Genomics (AVecGen) training programs in bioinformatics and molecular vector surveillance to build scientific capacity in Africa. The AVecGen training programs are capacity-building initiatives (not commercial products) focused on integrating genomic tools into vector control practices.
Differentiator
Problem solved
Functional benefit
Products and services
- Sanger Sequencing Service
Quantifiable outcome
- Researchers won first three prizes in all categories at PAMCA 2019 annual conference
- +2 more outcomes
Companies that use CRIDCam
Customer profileNamed customers2 records
Segments3 records
Ideal customer profiles3 records
CRIDCam technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
CRIDCam partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and minor.
- Liverpool School of Tropical Medicine (LSTM)coreCRID collaborates with LSTM on the Gates Foundation-funded project for detecting molecular markers of insecticide resistance in malaria vectors. The project involves a Cameroon-based team at CRID and a UK-based team at LSTM, working with partners in Ghana and Uganda. LSTM and CRID also partner on a Wellcome Trust Senior Research Fellowship project led by Dr. Cyrille Ndo.
- Abt Associates (Vectorlink Project)coreCRID has established a partnership with Abt Associates under the Vectorlink project in which CRID has been tasked to analyse all samples from the Vectorlink project in Cameroon to better inform vector control initiatives nation-wide. The partnership provides support from PMI entomologists including Dr. Etienne Fondjo as Chief of Party.
- Pan-African Mosquito Control Association (PAMCA)coreCRID actively participates in PAMCA activities and was a major award winner at the 6th PAMCA Annual Conference in Yaoundé. CRID contributes to PAMCA work streams through knowledge generation and sharing activities focused on analytics and practice of entomological findings.
- University of FloridaminorProf Rhoel Dinglasan from University of Florida and Director of CDC Southeastern Regional Center of Excellence for Vector Borne Diseases visited CRID to deliver a dengue science talk, exploring potential long-term collaboration on arboviruses and malaria research.
- World Health Organization (WHO)minorListed among CRID's institutional partners. WHO recognizes traditional medicine as part of knowledge systems that can contribute to health responses.
- London School of Hygiene & Tropical Medicine (LSHTM)minorListed among CRID's institutional partners and collaborators.
- Imperial College LondonminorListed among CRID's institutional partners and collaborators.
- University of GlasgowminorListed among CRID's institutional partners and collaborators.
- Index CamerounminorIndex Cameroun is listed among CRID's partners and collaborators, supporting the fight against infectious diseases in Cameroon.
- IVERM / PAMCAminorIVERM (International Vector Control Research) listed among partners. PAMCA (Pan-African Mosquito Control Association) has phase II grant on 'Strengthening local capacity for malaria surveillance and elimination in Africa' with CRID as implementing partner in Cameroon.
- IVERM / TVCAGminorCRID participates in TVCAG (Technical Vector Advisory Group) annual meetings, bringing together expert researchers, stakeholders, research fellows/students and media professionals to assess progress in vector-borne disease control.
- WHO/TDR (Special Programme for Research and Training in Tropical Diseases)minorListed among CRID's institutional partners and collaborators.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
CRIDCam competitors and assessment
Company assessmentBroad incumbents
- Swiss Tropical and Public Health Institute (Swiss TPH): Major European institute with extensive vector-borne disease, malaria, and capacity-building programmes across Africa, comparable research themes and donor base, but operating at much larger scale and global footprint.
- Institut de Recherche pour le Développement (IRD): French public research organisation with long-standing presence in francophone Africa conducting infectious disease and vector research, overlapping CRID's Cameroon-focused mission and partnership landscape.
- Africa Centres for Disease Control and Prevention (Africa CDC): Continental public-health body coordinating surveillance and response to infectious diseases across Africa. Sets priorities and channels funding that ultimately flows to research institutions like CRID.
- London School of Hygiene & Tropical Medicine (LSHTM): Large UK-based global health school with overlapping tropical disease, parasitology, and vector control research, frequently co-funding African institutes. Functions as both collaborator and competitor for the same grant pool.
Direct peers
- Liverpool School of Tropical Medicine (LSTM): Direct co-investigator on CRID's Gates-funded insecticide resistance project and a Wellcome Trust Senior Research Fellowship partner. Comparable research scope (vector biology, insecticide resistance, capacity building) at much larger scale.
- Kenya Medical Research Institute (KEMRI): Well-established African government-affiliated medical research institute conducting infectious disease and vector biology research with international funder backing. Directly comparable to CRID in mission, funding model, and scope.
- MRC Unit The Gambia at LSHTM: Long-standing West African infectious-disease research unit with integrated laboratory and field capabilities, comparable funding base, and similar focus on malaria, vector control and capacity building.
- Ifakara Health Institute: Tanzanian research organisation with comparable vector-borne disease, entomology, and field-trial capabilities, also operating across multiple African geographies and collaborating with similar international funders.
- Pasteur Institute of Cameroon: Yaoundé-based sister institute of the Institut Pasteur network conducting virology, parasitology and vector-borne disease research in the same Cameroonian ecosystem as CRID.
- Noguchi Memorial Institute for Medical Research (NMIMR): Leading Ghanaian biomedical research institute with strong vector-borne disease and parasitology programmes, also involved in Gates/Wellcome-funded malaria and insecticide resistance work alongside CRID's Ghana partners.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
CRIDCam social profiles
Digital presenceCRIDCam financial estimates
Financial estimateRevenue estimate
Valuation estimate
CRIDCam leadership team
Management profileNumber of profiles
CRIDCam funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CRIDCam M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CRIDCam
What does CRIDCam do?
CRIDCam (Centre for Research in Infectious Diseases) is a not-for-profit research institution based in Yaoundé, Cameroon, that conducts applied research on vector-borne infectious diseases — principally malaria and its Anopheles vectors — and provides specialized laboratory services, training programmes, and core research facilities. Its service portfolio includes Sanger sequencing, molecular vector surveillance, the AVecGen training curriculum (Bioinformatics and Vector Genomics, and Molecular Vector Surveillance), and access to its Molecular Biology Laboratory, Insectary, and Experimental Field Station for partner institutions and public-health agencies.
Is CRIDCam a public or private company?
CRIDCam is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was CRIDCam founded?
CRIDCam was founded in 2017. It employs 11 to 50 people.
Where is CRIDCam based?
CRIDCam is headquartered in Yaoundé, Cameroon, in the Africa region.
How does CRIDCam make money?
One revenue line is on record: research Grants and Donor Funding.
Who are CRIDCam's main competitors?
Broad incumbents on record are Swiss Tropical and Public Health Institute (Swiss TPH), Institut de Recherche pour le Développement (IRD), Africa Centres for Disease Control and Prevention (Africa CDC) and London School of Hygiene & Tropical Medicine (LSHTM). Direct peers are Liverpool School of Tropical Medicine (LSTM), Kenya Medical Research Institute (KEMRI), MRC Unit The Gambia at LSHTM, Ifakara Health Institute, Pasteur Institute of Cameroon and Noguchi Memorial Institute for Medical Research (NMIMR).
Does CRIDCam have an API?
No public API is recorded for CRIDCam.
What industry is CRIDCam in?
CRIDCam's product category is Infectious Disease Research Services. Its primary akta.pro industry code is HLAGAAAI, Patient Recruitment, Site Feasibility & Trial Enablement CROs, with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 5417 and its SIC code is 8731.